Effects of Sorafenib, a Tyrosin Kinase Inhibitor, on Adrenocortical Cancer

The lack of an effective medical treatment for adrenocortical carcinoma (ACC) has prompted the search for better treatment protocols for ACC neoplasms. Sorafenib, a tyrosine kinase inhibitor has exhibited effectiveness in the treatment of different human tumors. Therefore, the aim of this study was...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Front Endocrinol (Lausanne)
मुख्य लेखकों: Cerquetti, Lidia, Bucci, Barbara, Raffa, Salvatore, Amendola, Donatella, Maggio, Roberta, Lardo, Pina, Petrangeli, Elisa, Torrisi, Maria Rosaria, Toscano, Vincenzo, Pugliese, Giuseppe, Stigliano, Antonio
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Frontiers Media S.A. 2021
विषय:
Endocrinology
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8183165/
https://ncbi.nlm.nih.gov/pubmed/34108938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.667798
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन